1
|
Yount J, Morris M, Henson N, Zeller M, Byrd EFC, Piercey DG. Sequential, Electrochemical-Photochemical Synthesis of 1,2,4-Triazolo-[4,3-a]pyrazines. Chemistry 2024; 30:e202400661. [PMID: 38570880 DOI: 10.1002/chem.202400661] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2024] [Revised: 03/21/2024] [Accepted: 03/22/2024] [Indexed: 04/05/2024]
Abstract
1,2,4-triazolo-[4,3-a]pyrazine was prepared via a two-step electrochemical, photochemical process. First, a 5-substituted tetrazole is electrochemically coupled to 2,6-dimethoxypyrazine to yield 1,5- and 2,5- disubstituted tetrazoles. Subsequent photochemical excitation of the 2,5-disubstituted tetrazole species using an ultraviolet lamp releases nitrogen gas and produces a short-lived nitrilimine intermediate. Subsequent cyclization of the nitrilimine intermediate yields a 1,2,4-triazolo-[4,3-a]pyrazine backbone. The scope of this reaction was explored using various tetrazoles and pyrazines. Materials produced were identified using chemical analytical techniques and computationally studied for potential application as an insensitive energetic material.
Collapse
Affiliation(s)
- Joseph Yount
- School of Materials Engineering, Purdue University, 205 Gates Road, West Lafayette, IN, 47906, USA
- Purdue Energetics Research Center, Purdue University 2, 05 Gates Road, West Lafayette, IN, 47906, USA
| | - Megan Morris
- Department of Pharmacy Practice, Purdue University, 575 Stadium Mall Dr, West Lafayette, IN, 47907, USA
| | - Noah Henson
- Department of Chemistry, Purdue University, 560 Oval Drive, West Lafayette, IN, 47906, USA
| | - Matthias Zeller
- Department of Chemistry, Purdue University, 560 Oval Drive, West Lafayette, IN, 47906, USA
| | - Edward F C Byrd
- Detonation Sciences & Modeling Branch, DEVCOM Army Research Laboratory, Aberdeen Proving Ground, MD, 21005, USA
| | - Davin G Piercey
- School of Materials Engineering, Purdue University, 205 Gates Road, West Lafayette, IN, 47906, USA
- Purdue Energetics Research Center, Purdue University 2, 05 Gates Road, West Lafayette, IN, 47906, USA
- School of Mechanical Engineering, Purdue University, 585 Purdue Mall, West Lafayette, IN, 47906, USA
| |
Collapse
|
2
|
Jethava DJ, Borad MA, Bhoi MN, Acharya PT, Bhavsar ZA, Patel HD. New dimensions in triazolo[4,3-a]pyrazine derivatives: The land of opportunity in organic and medicinal chemistry. ARAB J CHEM 2020. [DOI: 10.1016/j.arabjc.2020.09.038] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023] Open
|
3
|
Jethava DJ, Acharya PT, Vasava MS, Bhoi MN, Bhavsar ZA, Rathwa SK, Rajani DP, Patel HD. Design, synthesis, biological evaluation and computational study of novel triazolo [4,3-a]pyrazin analogues. J Mol Struct 2019. [DOI: 10.1016/j.molstruc.2019.01.091] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
4
|
Bogen SL, Ruan S, Liu R, Agrawal S, Pichardo J, Prongay A, Baroudy B, Saksena AK, Girijavallabhan V, Njoroge FG. Depeptidization efforts on α-ketoamide inhibitors of HCV NS3-4A serine protease: Effect on HCV replicon activity. Bioorg Med Chem Lett 2006; 16:1621-7. [PMID: 16387495 DOI: 10.1016/j.bmcl.2005.12.013] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2005] [Revised: 11/03/2005] [Accepted: 12/07/2005] [Indexed: 11/20/2022]
Abstract
Depeptidization efforts of the P(3)-P(2) region of P(3) capped alpha-ketoamide inhibitor of HCV NS3 serine protease 1 are reported. We clearly established that N-methylation of the P(2) nitrogen and modification of the P(2)' carboxylic acid terminus were essential for activity in the replicon assay.
Collapse
Affiliation(s)
- Stéphane L Bogen
- Schering-Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, NJ 07033, USA.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Clozel JP, Fischli W. Comparative effects of three different potent renin inhibitors in primates. Hypertension 1993; 22:9-17. [PMID: 8319997 DOI: 10.1161/01.hyp.22.1.9] [Citation(s) in RCA: 23] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
The goal of the present study was to compare the effects of three potent reference renin inhibitors (remikiren, CGP 38560A, and enalkiren) in sodium-depleted normotensive squirrel monkeys. In these monkeys, arterial pressure was measured in the conscious state with a telemetry system. Oral and intravenous maximal effective doses of the three renin inhibitors were compared in parallel groups of monkeys. In additional experiments, remikiren was given on top of either CGP 38560A or enalkiren in the same animals. Finally, the three drugs were compared with the angiotensin converting enzyme inhibitor cilazapril. The effects of the three drugs on the plasma components of the renin-angiotensin system (plasma renin activity, immunoreactive renin, and immunoreactive angiotensin II concentrations) were also measured. Our results show that remikiren was as effective as cilazapril and markedly more effective than CGP 38560A or enalkiren in reducing arterial pressure in our monkey model. Interestingly, these differences in arterial pressure could not be explained by differences of in vitro potency or different biochemical changes of the plasma components of the renin-angiotensin system, because the inhibitors all reduced immunoreactive angiotensin II to similarly low levels. One possible explanation is that, in our model, remikiren in contrast to CGP 38560A and enalkiren is able to inhibit renin in a functionally important extraplasmatic compartment.
Collapse
Affiliation(s)
- J P Clozel
- Pharma Division, Preclinical Research, F. Hoffmann-La Roche Ltd, Basel, Switzerland
| | | |
Collapse
|